Muscarinic Antagonists: all 1,032 studies that test it
Page 9 of 11. Open to participants first (107), then studies with results posted, then the rest; newest registration first within each.
- Study to Assess the Safety and PK of GSK573719 and GSK573719/GW642444(VI) Combination in Healthy Subjects and Subjects With Severe Renal ImpairmentCompletedNCT01571999Phase 1
- A Study To Estimate The Effects Of Food On Drug Fesoterodine Fumarate And The Pharmacokinetics Of 5-Hydroxymethyl Tolterodine (5-HMT) In Healthy VolunteersCompletedNCT01566760Phase 1
- Single Dose Study to Measure Blood Levels and Safety of a Drug for Children With Overactive BladderCompletedNCT01539707Phase 1
- Atropin and Glucose Stimulated Insulinsecretion and the Cephalic Insulin ResponseStatus unknownNCT01534442Not applicable
- Efficacy and Tolerability of Propiverine Hydrochloride in Patients With Neurogenic Detrusor OveractivityCompletedNCT01530620Phase 3
- Pharmacokinetics and Relative Bioavailability StudyCompletedNCT01521767Phase 1
- Assessment of Lung Function After Single Inhalations of a Bronchodilator From 2 Configurations a Dry Powder Inhaler.CompletedNCT01521390Phase 1
- QTc Study GSK573719+GW642444CompletedNCT01521377Phase 1
- Propiverine Hydrochloride Extended-Release Capsule for Overactive BladderCompletedNCT01512004Phase 3
- A Study to Estimate the Efficacy and Safety of Solifenacin in Female With Stress Urinary Incontinence and Urgency Urinary IncontinenceCompletedNCT01505439Phase 4
- Studies of Psychiatric Predisposing Factors, Treatment-related Cardiovascular Effects, and Prognostic Factors Associated With Antimuscarinic Drug (Tolterodine) for Female Overactive Bladder SyndromeCompletedNCT01503580Not applicable
- A Comparison Study of Oxybutynin and Botulinum Toxin for Neurogenic Detrusor OveractivityCompletedNCT01477736Not applicable
- Randomized Cross Over Study to Assess Efficacy and Safety of BDP/FF and GlycopyrrolateCompletedNCT01476813Phase 2
- Evaluate the Effects of Formoterol and Beclomethasone Dipropionate Combination Therapy on Small Airways FunctionStatus unknownNCT01466712Phase 4
- Efficacy and Safety of Tulobuterol Patch Combined With Tiotropium Bromide for Relieving Dyspnea Symptom of Chronic Obstructive Pulmonary DiseaseStatus unknownNCT01465906Phase 4
- Intubation Time With Low Dose RocuroniumCompletedNCT01464489Not applicable
- A Phase 2 Study to Compare the Efficacy and Tolerability of Tarafenacin 0.2 mg and Tarafenacin 0.4 mg to Placebo in Patients Suffering From Overactive Bladder.CompletedNCT01458197Phase 2
- Tiotropium In Early Chronic Obstructive Pulmonary Disease Patients in ChinaCompletedNCT01455129Phase 4
- Street Fitness in Surgical Patients Undergoing General Anesthesia After Reversal of Neuromuscular BlockadeStatus unknownNCT01453530Phase 4
- The Effects of Bethanechol on Glucose HomeostasisCompletedNCT01434901Phase 1
- Bioavailability of Vagantin® Coated Tablets Relative to an Oral Methantheline Bromide SolutionCompletedNCT01429090Phase 1
- Influence of Premedication Protocols for Neonatal Endotracheal Intubation on Cerebral OxygenationCompletedNCT01427985Phase 4
- Comparison of Solifenacin and Oxybutynin in the Treatment of Overactive BladderStatus unknownNCT01423838Phase 4
- A Study in Healthy Volunteers Comparing Two Different Liquid Formulations of Solifenacin With Each Other and With the Tablet FormulationCompletedNCT01406158Phase 1
- Pharmacokinetic Interaction Study of Glycopyrrolate and Formoterol in Healthy VolunteersCompletedNCT01398111Phase 1
- Effects of Anticholinergic or Long-Acting Beta 2 Agonist on FeNO and Pulmonary Function in SCIStatus unknownNCT01355991Phase 1
- A Study to Compare Oxybutynin to a Placebo in Women and the Effect on Plantar HyperhidrosisCompletedNCT01328015Phase 2
- A Study to Evaluate Response of Over Active Bladder Symptom Score to Solifenacin TreatmentCompletedNCT01318837Phase 4
- Use of Oxybutynin for Treating Hyperhidrosis: A Placebo-control StudyCompletedNCT01310712Phase 4
- Pharmacokinetics of the Fixed Dose Combination of Tiotropium Plus BI 54903 Versus the Combination of the Monoproducts of Tiotropium and BI 54903 in Healthy VolunteersCompletedNCT01309139Phase 1
- Effects of Tiotropium on Walking Capacity in Patients With COPDCompletedNCT01307189Phase 4
- A Clinical Study to Assess the Effect on Pharmacokinetics of Dosing Mirabegron (YM178) and Solifenacin SimultaneouslyCompletedNCT01297192Phase 1
- Bladder Wall Blood Perfusion Pattern and Sexual Dysfunction in Female Patients With Lower Urinary Tract Symptoms, and the Association of That Perfusion Pattern and Therapeutic Efficacy of Antimuscarincs for Female Overactive Bladder Syndrome.CompletedNCT01282840Not applicable
- Patient Preferences, Analgesic Delivery Method and Pain Reduction in Spine PatientsWithdrawnNCT01263652Not applicable
- Single-dose Study to Assess Pharmacokinetics of Solifenacin Succinate Suspension in Children and AdolescentsCompletedNCT01262391Phase 1
- Meperidine Versus Drotaverine Regarding the Effect on the Duration of the First Stage of Labor in Full Term PrimigravidaeStatus unknownNCT01236651Phase 2
- Single Dose Bioequivalence Study of Darifenacin Tablets 7.5 mg in Fed Healthy Volunteers.Status unknownNCT01229280Phase 1
- Single Dose Two-periods Crossover Bioequivalence Study of Darifenacin Tablets in Healthy Volunteers.Status unknownNCT01227811Phase 1
- Scopolamine Challenge StudyCompletedNCT01213355Phase 1
- A Double-blind Comparison of Scopolamine With Cinnarizin for Prevention of Simulator SicknessStatus unknownNCT01198106Not applicable
- STUDY The Effect of HNF-4A G60D Variant on the In VIVO CYP2D6 Activity By Tolterodine Pharmacokinetic StudyCompletedNCT01181505Phase 1
- Safety and Efficacy Study of Glyco pMDI After Single and Repeated AdministrationCompletedNCT01176903Phase 1/2
- Biopharmaceutical Study of Glyco pMDI With or Without Charcoal Block vs IV Bolus in Healthy VolunteersCompletedNCT01176851Phase 1
- Study of a Tiotropium Inhaler For Shortness of Breath in Advanced Non-Small Cell Lung CancerStatus unknownNCT01172925Phase 2
- Pharmacokinetic and Safety of GSK573719 and GW642444 Administered Individually and Concurrently, With Verapamilin in Healthy SubjectsCompletedNCT01128634Phase 1
- Use of Oxybutynin to Treat Axillary HyperhidrosisCompletedNCT01118429Not applicable
- GSK573719 IV Enabling StudyCompletedNCT01110018Phase 1
- Clinical Trial of Solifenacin Versus Placebo Plus Pessary for Women With Vaginal ProlapseTerminatedNCT01092624Phase 4
- Study on Effective Mydriasis in Premature InfantsCompletedNCT01054027Not applicable
- OnabotulinumtoxinA (onaBoNT-A) Versus Oral Oxybutynin ERStatus unknownNCT01050114Phase 3
- Use of Biperiden for the Prevention of Post-traumatic EpilepsyTerminatedNCT01048138Phase 3
- A Study of YM178 in Subjects With Symptoms of Overactive BladderCompletedNCT01043666Phase 3
- Effects of Novel Combinations of Tolterodine/Pilocarpine on Pharmacokinetics (PK) and Pharmacodynamics (PD) of Tolterodine in Healthy SubjectsCompletedNCT01036035Phase 1
- Exploratory Study Evaluating the Effects of Darifenacin on Nocturia, Sleep and Daytime WakefulnessWithdrawnNCT01018225Phase 4
- Relative Bioavailability Study of Solifenacin Succinate Liquid Suspension (Fed and Fasting) Versus VESIcare Tablet (Fasting) in Healthy VolunteersCompletedNCT01015040Phase 1
- A Study of GSK573719 in Healthy Japanese Male SubjectsCompletedNCT01013974Phase 1
- Effects of GABA-a-Agonists on Pain Mechanisms: An Experimental Study in Healthy VolunteersCompletedNCT01011036Phase 3
- Compare the Therapeutic Effect Treated With Tamsulosin and Progesterone After ESWL( Extra Corporeal Shock Wave Lithotripsy) in Urinary CalculusStatus unknownNCT01010048Phase 4
- Differential Trough Effects of 'Triple Therapy' on Pulmonary Function in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00996697Phase 4
- The Effect of Extended-Release Oxybutynin Chloride on Vasomotor Symptoms in Healthy Post-Menopausal WomenCompletedNCT00990886Phase 2
- Interaction in Chronic Obstructive Pulmonary Disease ExperimentCompletedNCT00981851Not applicable
- Solifenacin Flexible Dosing Study in Frequent Micturition Patients With and Without UrgencyCompletedNCT00979472Phase 4
- Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of GSK573719 (LAMA) and GW642444 (LABA)Administered Individually and Concurrently in Healthy Japanese SubjectsCompletedNCT00976144Phase 1
- Phase I Study of GSK233705 in Healthy Japanese Male SubjectsCompletedNCT00964405Phase 1
- A Study of Inhaled Atropine Sulfate in Healthy AdultsCompletedNCT00947596Phase 1
- Effects of Oxybutynin Topical Gel on Gastric EmptyingCompletedNCT00926926Phase 1
- Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH)CompletedNCT00922506Phase 4
- Atropine to Prevent Nausea and Vomiting After Spinal Anesthesia for Caesarean SectionCompletedNCT00921102Phase 4
- The Effect Of Fesoterodine On Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy SubjectsCompletedNCT00914667Phase 1
- Efficacy Study of Tamsulosin and Tolterodine Treatment for Chronic ProstatitisStatus unknownNCT00913315Not applicable
- Study to Assess the Effect of Salbutamol and Ipratropium Bromide in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00911651Phase 4
- The Effect Of Fluconazole On Pharmacokinetics Of Fesoterodine In Healthy SubjectsCompletedNCT00911235Phase 1
- Evaluation of Breathing Pattern and Dyspnea in Subjects With TetraplegiaCompletedNCT00904436Not applicable
- Urinary Urgency Outcomes Following Propiverine Treatment for an Overactive BladderCompletedNCT00903045Phase 4
- A Bioequivalence Study Of 8 Mg Fesoterodine Extended-Release Tablets (Toviaz™) In Healthy SubjectsCompletedNCT00902681Phase 1
- A Bioequivalence Study Of 4 Mg Fesoterodine Extended-Release Tablets (Toviaz™) In Healthy SubjectsCompletedNCT00902187Phase 1
- Anticholinergic Therapy for Overactive Bladder in Parkinson's DiseaseCompletedNCT00892450Not applicable
- A Study to Evaluate Add on Effect of Solifenacin in Men With Overactive Bladder Symptoms After Tamsulosin Monotherapy for 4 WeeksCompletedNCT00884104Phase 4
- Comparison of Instillation and Packing in Mydriasis for Premature InfantsCompletedNCT00877175Phase 4
- Study to Evaluate the Safety and Efficacy of Inhaled PT001 in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00871182Phase 1/2
- Clinical Outcomes of Tiotropium Plus Fluticasone Propionate/Salmeterol Compared With Tiotropium for Chronic Obstructive Pulmonary Disease (COPD) in KoreaCompletedNCT00864812Phase 4
- Study of Darifenacin in Patients Suffering From Multiple Sclerosis and Neurogenic Detrusor OveractivityTerminatedNCT00845338Phase 2
- Assessment of Patient-reported Goal Attainment in the Treatment of Female Overactive BladderCompletedNCT00836381Phase 4
- Adjunctive Atropine During Ketamine SedationCompletedNCT00834470Phase 4
- Desloratadine With Oxybutynin for the Treatment of Seasonal Allergic Rhinitis and Post-Nasal Drip (Study P04258)(COMPLETED)CompletedNCT00816972Phase 2
- Remifentanil and Atropine for Intubation in NeonatesCompletedNCT00815048Phase 4
- Sensitivity of New Exercise Tests in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00807534Not applicable
- Phase 1, Single Dose, Crossover Study to Determine Bioequivalence and to Investigate Food EffectCompletedNCT00807118Phase 1
- Solifenacin Succinate Versus Tolterodine 4mg Once DailyCompletedNCT00802373Phase 3
- Solifenacin Succinate 5mg or 10mg Once Daily in the Treatment of Urgency SymptomsCompletedNCT00801944Phase 3
- Comparative Study of the Efficacy and Safety of Muscarinic M3 Receptors Antagonists in the Treatment of Neurogenic Detrusor OveractivityCompletedNCT00800462Phase 4
- Dose-Escalating Study of Propiverine Hydrochloride in Children Suffering From Overactive BladderCompletedNCT00795925Phase 2
- Phase1, Single Dose, Crossover Study to Determine BioequivalenceCompletedNCT00786240Phase 1
- Bronchodilators and Respiratory Mechanics in Chronic Obstructive Pulmonary Disease (COPD) PatientsTerminatedNCT00783250Phase 4
- A Study to Assess the Safety and Pharmacokinetics of Inhaled Doses of GSK233705 and GW642444 in Healthy SubjectsCompletedNCT00783003Phase 1
- Solifenacin Succinate Versus Placebo in Inner City Women Ages 20-45 With Overactive BladderWithdrawnNCT00773552Phase 4
- Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Benign Prostatic HyperplasiaCompletedNCT00771394Phase 4
- A Study of Oxybutynin for the Treatment of Urge Urinary IncontinenceCompletedNCT00749632Phase 2
- The Pathophysiology of Orthostatic HypotensionCompletedNCT00748059Phase 1
- Investigation of Tolterodine, Pregabalin and a Tolterodine - Pregabalin Combination for the Treatment of Overactive BladderCompletedNCT00746681Phase 2